Glucocorticoids May Reduce Mortality in Community-Acquired Pneumonia
Episode Summary
Adjunctive glucocorticoids may improve outcomes in hospitalized community-acquired pneumonia, offering a low-cost, scalable strategy to reduce mortality and strengthen care in resource-limited settings.